← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2003Last known activity
Aug 1, 2007
Defunct as of Dec 31, 2009
Timeline
1990s
- Jun 1, 1993
AtheroGenics— Founded
2000s
- Dec 31, 2009
AtheroGenics— Defunct
Drugs by trial phase (1 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT00525577Lead sponsorPhase 2/Phase 3Aug 1, 2007
- NCT00525577Study chairPhase 2/Phase 3Aug 1, 2007
- NCT00066898Lead sponsorPhase 3Jun 1, 2003
Details
- Founded
- Alpharetta, GA, US Jun 1, 1993
- Last known activity
- Aug 1, 2007